1.
Du J, Huo J, Shi J, Yuan Z, Zhang C, Fu W, Jiang H, Yi Q, Hou J. Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens. Haematologica [Internet]. 2011Apr.29 [cited 2026Nov.10];96(5):729-37. Available from: https://haematologica.org/article/view/5969